Skip to main content

Table 2 Cycle characteristics and embryological data of studied groups

From: IVF/ICSI outcomes of euthyroid infertile women with thyroid autoimmunity: does treatment with aspirin plus prednisone matter?

Cycles

Fresh embryo transfer cycles

Frozen-thawed embryo transfer cycles

Control group n = 113

P + A group n = 74

P value

Control group n = 83

P + A group n = 76

P value

GnRHant/GnRHa

Total Gn Dose (IU)

28/85

2250.0 (1575.0-2700.0)

23/51

2250.0 (1762.5-2925.0)

0.344

0.373

38/45

1950.0 (1425.0-2550.0)

27/49

1875.0 (1425.0-2225.0)

0.189

0.437

Stimulation length (d)

10.0 (9.0-11.0)

10.0 (9.0-11.0)

0.442

9.0 (8.0-11.0)

9.0 (8.0-11.0)

0.897

E2 level on HCG day (pg/mL)

2246.77 ± 980.18

2287.10 ± 865.47

0.547

3449.1 (2076.4-4496.1)

3811.1 (2293.9-5959.9)

0.486

Endometrial thickness on hCG day (mm)

12 (10-12)

12 (10-12)

0.444

/

/

/

Number of oocytes retrieved

9.0 (5.0-12.0)

10.0 (6.0-15.0)

0.053

12.0 (9.0-17.0)

15.5 (9.0-21.8)

0.057

IVF/ICSI

102/11

70/4

0.287

70/13

65/11

0.834

Fertilization rate (%)

82.6 (846/1024)

80.4 (634/789)

0.217

81.0 (856/1057)

78.0 (973/1247)

0.080

Cleavage rate (%)

92.7 (784/846)

93.5 (593/634)

0.519

95.7 (819/856)

94.3 (918/973)

0.194

Available embryo rate (%)

61.2 (480/784)

56.2 (333/593)

0.058

56.8 (465/819)

55.4 (509/918)

0.577

  1. P < 0.05 was considered statistically significant
  2. Continuous data are expressed as mean±SD when normally distributed, or as median (25th-75th) otherwise. Categorical variables are expressed as number and percentage
  3. GnRHant gonadotropin-releasing hormone antagonist, GnRHa gonadotropin-releasing hormone agonist, Gn dose gonadotropin dose, E2 estradiol, hCG human chorionic gonadotropin, IVF in vitro fertilization, ICSI intracytoplasmic sperm injection